Randy L. Jensen,
MD, PhD
Languages Spoken: English, Japanese
Labs: Website
Dr. Randy Jensen specializes in Neurosurgery, Brain Tumors, Skull Base Surgery, Neuro Trauma and Neurocritical Care. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.
Clinical Locations
801-585-6065
Patient Care Center
801-585-0260
Board Certification and Academic Information
| Academic Departments | Neurosurgery
-
Professor Oncological Sciences - Adjunct Professor Radiation Oncology - Adjunct Professor |
| Academic Divisions | Adult Neurosurgery |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 25, 2022
HUNTSMAN CANCER CENTER
Dr Jensen brought in students with out my permission and also he didn't address the major concerns I had
UofU Patient
March 25, 2022
HUNTSMAN CANCER CENTER
Dr. Jensen and his staff were very professional and courteous through out my visit.
UofU Patient
February 18, 2022
HUNTSMAN CANCER CENTER
The Doctor was very thorough and gave me full understanding about my tumor. Very well verse with the kind of tumor I have and explained It very well.
UofU Patient
February 01, 2022
HUNTSMAN CANCER CENTER
Dr Jensen is so kind and attentive. He's one of the best doctors I've met!
UofU Patient
January 14, 2022
HUNTSMAN CANCER CENTER
Love the staff they were very patient with a grumpy fart
UofU Patient
January 14, 2022
HUNTSMAN CANCER CENTER
My first time in hospital overnight. I could live there !!! VERY excellent care and instructions.
UofU Patient
January 12, 2022
HUNTSMAN CANCER CENTER
I genuinely felt cared for Thank you!
UofU Patient
January 08, 2022
HUNTSMAN CANCER CENTER
Dr. Jensen and his staff were most helpful. Dr. Jensen in particular was attentive and listening and very gracious in his care of [NAME REMOVED]
UofU Patient
December 07, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen was very compassionate and answered all my questions. I appreciated his concern and professionalism.
UofU Patient
November 27, 2021
HUNTSMAN CANCER CENTER
Excellent!!
UofU Patient
November 27, 2021
HUNTSMAN CANCER CENTER
We were so happy with the kindness and personal care Dr Jensen have to us!!
UofU Patient
September 17, 2021
HUNTSMAN CANCER CENTER
I was always informed on procedures that were part of my treatment. And my decision to go with a particular surgery was discussed with the nurse and doctors. Other types of surgeries were also discussed.
UofU Patient
August 13, 2021
HUNTSMAN CANCER CENTER
All good
UofU Patient
July 11, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen was kind, personable and within minutes I felt at ease and instantly trusted his opinions and judgment.
UofU Patient
June 18, 2021
HUNTSMAN CANCER CENTER
we discussed radiation of a tumor that we thought had been done already. he explained they hadn't done radiation on the tumor because it was complicated but did not explain what made it complicated or the risks of radiation to that particular tumor
UofU Patient
June 05, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen was warm and sincere
UofU Patient
April 26, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen took great care of me. He explained my surgery and answered all of my questions. I feel like I can reach out to him with any questions I have.
UofU Patient
April 23, 2021
HUNTSMAN CANCER CENTER
Always and excellent experience.
UofU Patient
April 21, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen is the best.
UofU Patient
April 02, 2021
HUNTSMAN CANCER CENTER
excellent discussion and bedside manner
UofU Patient
March 26, 2021
HUNTSMAN CANCER CENTER
We think the world of Dr. Jensen - we are very pleased with all he has done for me.
UofU Patient
March 24, 2021
HUNTSMAN CANCER CENTER
The experience of Dr Jensen in knowing others with longer lives than expected with this serious prognosis was hopeful.
UofU Patient
March 15, 2021
HUNTSMAN CANCER CENTER
I would recommend Dr. Jensen to anyone needing a neurosurgeon!!!
UofU Patient
February 27, 2021
HUNTSMAN CANCER CENTER
They were very informative, answering my questions as well as giving me information I had not been told by my other doctor which I was thankful for. Each and every person I dealt with was very helpful and caring about me
UofU Patient
February 01, 2021
HUNTSMAN CANCER CENTER
Dr. Jensen is the best doctor I have ever seen.
UofU Patient
January 17, 2021
HUNTSMAN CANCER CENTER
I was told the proposed course of treatment, but then asked to call the nurse to get the details. when I called the nurse, I was treated very poorly AND the treatment was different than we discussed. i feel it should be the doctor's responsibility to communicate treatment plans to the nurse and then contact me. I don't think I should have to do the run around to know how to move forward and they should all be on the same page. Clearly, the doctor never notated or communicated to his nurse what we had discussed.
UofU Patient
December 20, 2020
HUNTSMAN CANCER CENTER
Dr Jensen is not just extremely knowledgeable, he is also extremely compassionate. I appreciate his bedside manner.
UofU Patient
December 13, 2020
HUNTSMAN CANCER CENTER
Dr. Jensen showed he actually cares which was nice
UofU Patient
December 07, 2020
HUNTSMAN CANCER CENTER
Dr Jensen is always very pleasant and caring. He always takes the time to explain everything well. He makes you feel comfortable and assured you will be well taken care of.
UofU Patient
December 04, 2020
HUNTSMAN CANCER CENTER
I've had some rough experiences previously. Dr Jensen was a breath of fresh air.
UofU Patient
November 27, 2020
HUNTSMAN CANCER CENTER
There examintion exultant
UofU Patient
November 22, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
November 22, 2020
HUNTSMAN CANCER CENTER
Dr. Jensen is great. great bedside manner, easy going, give facts and his suggestions but leaves the decision up to you. answered all my questions.
UofU Patient
November 22, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
November 20, 2020
HUNTSMAN CANCER CENTER
doctor was excellent friendly and professional. easy to talk to
UofU Patient
November 06, 2020
HUNTSMAN CANCER CENTER
He was so easy to talk to and very knowledgeable
UofU Patient
September 28, 2020
HUNTSMAN CANCER CENTER
Dr.Jensen was very personable and down to earth. I wasn't enthusiastic about meeting with him and having an appointment.After my appointment I was glad I was able to meet with him. I would highly recommend him.
UofU Patient
September 26, 2020
HUNTSMAN CANCER CENTER
dr. Jensen was very straightforward but not pushy. very nice
UofU Patient
September 19, 2020
HUNTSMAN CANCER CENTER
my dr is very good and listens well
UofU Patient
August 30, 2020
HUNTSMAN CANCER CENTER
Just don't see how it could be any better!
UofU Patient
August 29, 2020
HUNTSMAN CANCER CENTER
I cannot express how much easier it was to do my apt virtually. the appt took about 15 minutes total rather than at least two hours if I had to drive up to HCH.
UofU Patient
August 12, 2020
HUNTSMAN CANCER CENTER
no complaints. Dr. Jensen is the best!
UofU Patient
August 08, 2020
HUNTSMAN CANCER CENTER
Dr. Jensen spoke up so I could hear him.
UofU Patient
June 15, 2020
HUNTSMAN CANCER CENTER
Dr. Jensen was and is phenomenal. He answered all of our questions and addressed all of our concerns. He was great at explaining the various options and ways in which we could move forward.
Dr. Randy Jensen specializes in Neurosurgery, Brain Tumors, Skull Base Surgery, Neuro Trauma and Neurocritical Care. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Neurosurgery
-
Professor Oncological Sciences - Adjunct Professor Radiation Oncology - Adjunct Professor |
| Academic Divisions | Adult Neurosurgery |
Research Interests
- Hypoxia, Brain
- Hypoxia Inducible Factor-1
- Calcium Channel Antagonists
- Cox-2
- Diphtheria toxin-conjugated monoclonal antibody
- IL-13 receptors
- Gliasite
- Phase II 131-I
- Stereotactic radiosurgery versus surgery for single brain metastasis
Education History
| Doctoral Training | Loyola University Medical Center Ph.D., 1998 |
| Residency | Loyola University of Chicago Neurosurgery Resident, 1997 |
| Professional Medical | University of Utah Hospital School of Medicine Medicine M.D., 1991 |
| Undergraduate | University of Utah Chemistry B.A., 1987 |
| Undergraduate | University of Utah Biology B.S., 1987 |
| Fellowship | University of Utah Healthcare, Academy of Health Science Educators Fellow, |
| Graduate Training | University of Illinois Neurosurgery MHPE, |
Selected Publications - Journal Articles
Journal Article
- Lehman NL, Spassky N, Sak M, Webb A, Zumbar CT, Usubalieva A, Alkhateeb KJ, McElroy JP, Maclean KH, Fadda P, Liu T, Gangalapudi V, Carver J, Abdullaev Z, Timmers C, Parker JR, Pierson CR, Mobley BC, Gokden M, Hattab EM, Parrett T, Cooke RX, Lehman TD, Costinean S, Parwani A, Williams BJ, Jensen RL, Aldape K, Mistry AM (2022). Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. Nat Commun, 13(1), 2083.
- Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Lillehei KO, Jensen RL, Youssef AS, Ormond DR, Graner MW (2022). Targeting DNA Methyl Transferases with Decitabine in Cultured Meningiomas. World Neurosurg.
- Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250.
- Dunson B, Park YS, Richards B, Hirshfield LE, Jensen RL (2021). Longitudinal Comparison of Continuing Medical Education Learning Objectives and Intent-to-Change Statements of Participants. J Contin Educ Health Prof.
- Tatman PD, Wroblewski TH, Fringuello AR, Scherer SR, Foreman WB, Damek DM, Lillehei K, Youssef AS, Jensen RL, Graner MW, Ormond DR (2021). High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas. J Clin Med, 10(14).
- Kim RB, Scoville JP, Karsy M, Lim S, Jensen RL, Menacho ST (2021). Work relative value units and perioperative outcomes in patients undergoing brain tumor surgery. Neurosurg Rev, 45, 719-728.
- Jensen RL, Kestle JRW, Brockmeyer DL, Couldwell WT (2020). Principles of Remediation for the Struggling Neurosurgery Resident. World Neurosurg, 146, e1118-e1125.
- Yahanda AT, Patel B, Shah AS, Cahill DP, Sutherland G, Honeycutt J, Jensen RL, Rich KM, Dowling JL, Limbrick DD, Dacey RG, Kim AH, Leuthardt EC, Dunn GP, Zipfel GJ, Leonard JR, Smyth MD, Shah MV, Abram SR, Evans J, Chicoine MR (2020). Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study. Neurosurgery, 88(1), 63-73.
- Shah AS, Yahanda AT, Sylvester PT, Evans J, Dunn GP, Jensen RL, Honeycutt J, Cahill DP, Sutherland GR, Oswood M, Shah M, Abram SR, Rich KM, Dowling JL, Leuthardt EC, Dacey RG, Kim AH, Zipfel GJ, Limbrick DD, Smyth MD, Leonard J, Chicoine MR (2019). Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter Study. Neurosurgery, 88(1), E49-E59.
- Shah AS, Sylvester PT, Yahanda AT, Vellimana AK, Dunn GP, Evans J, Rich KM, Dowling JL, Leuthardt EC, Dacey RG, Kim AH, Grubb RL, Zipfel GJ, Oswood M, Jensen RL, Sutherland GR, Cahill DP, Abram SR, Honeycutt J, Shah M, Tao Y, Chicoine MR (2020). Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery. J Neurosurg, 1-10.
- Pedersen BS, Bhetariya PJ, Brown J, Kravitz SN, Marth G, Jensen RL, Bronner MP, Underhill HR, Quinlan AR (2020). Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome Med, 12(1), 62.
- Cohen AL, Anker CJ, Johnson B, Burt LM, Shrieve DC, Salzman K, Jensen R, Boucher K, Colman H (2020). Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial. J Neurooncol, 148(3), 577-585.
- Ponnapalli SP, Bradley MW, Devine K, Bowen J, Coppens SE, Leraas KM, Milash BA, Li F, Luo H, Qiu S, Wu K, Yang H, Wittwer CT, Palmer CA, Jensen RL, Gastier-Foster JM, Hanson HA, Barnholtz-Sloan JS, Alter O (2020). Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival. APL Bioeng, 4(2), 026106.
- Yahanda AT, Patel B, Sutherland G, Honeycutt J, Jensen RL, Smyth MD, Limbrick DD Jr, Dacey RG Jr, Dowling JL, Dunn GP, Kim AH, Leuthardt EC, Rich KM, Zipfel GJ, Leonard JR, Cahill DP, Shah MV, Abram SR, Evans J, Tao Y, Chicoine MR (2019). A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas. World Neurosurg, 135, e754-e764.
- Tiburcio PDB, Gillespie DL, Jensen RL, Huang LE (2020). Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential. J Neurooncol, 146(3), 427-437.
- Bounajem MT, Karsy M, Jensen RL (2019). Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons. Neurosurg Focus, 48(1), E8.
- Burnett BA, Womeldorff MR, Jensen R (2020). Meningioma: Signaling pathways and tumor growth. Handb Clin Neurol, 169, 137-150.
- Weaver BD, Goodman JR, Jensen R (2019). Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review. Cureus, 11(11), e6147.
- Smith N, Saunders D, Jensen RL, Towner RA (2019). Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model. J Neurosurg, 1-9.
- Giles AJ, Hao S, Padget M, Song H, Zhang W, Lynes J, Sanchez V, Liu Y, Jung J, Cao X, Fujii R, Jensen R, Gillespie D, Schlom J, Gilbert MR, Nduom EK, Yang C, Lee JH, Soon-Shiong P, Hodge JW, Park DM (2019). Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight, 4(20).
- Sherrod BA, Gamboa NT, Wilkerson C, Wilde H, Azab MA, Karsy M, Jensen RL, Menacho ST (2019). Effect of patient age on glioblastoma perioperative treatment costs: a value driven outcome database analysis. J Neurooncol, 143(3), 465-473.
- Zhang XC, Lipman J, Jensen R, Parekh K (2019). Thematic Analysis of Emergency Medicine Applicants' Personal Statements. Med Sci Educ, 29(3), 659-665.
- Ronna B, Guan J, Karsy M, Service J, Ekins A, Jensen R (2019). A Survey of Neurosurgery Residency Program Coordinators: Their Roles, Responsibilities, and Perceived Value. Cureus, 11(4), e4457.
- Yang I, Udawatta M, Prashant GN, Lagman C, Bloch O, Jensen R, Sheehan J, Kalkanis S, Warnick R (2018). Stereotactic Radiosurgery for Neurosurgical Patients: A Historical Review and Current Perspectives. World Neurosurg, 122, 522-531.
- Yang I, Udawatta M, Prashant GN, Preet K, Mekonnen M, Duong C, Sheppard JP, Nguyen T, Bloch O, Jensen R, Sheehan J, Kalkanis S, Warnick RE (2018). Commentary: Stereotactic Radiosurgery Training for Neurosurgery Residents: Results of a Survey of Residents, Attendings, and Program Directors by the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors. Neurosurgery, 84(1), E86-E91.
- Karsy M, Burnett B, Di Ieva A, Cusimano MD, Jensen RL (2018). Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. J Neurosurg, 128(3), 657-666.
- Guan J, Brock AA, Karsy M, Couldwell WT, Schmidt MH, Kestle JRW, Jensen RL, Dailey AT, Schmidt RH (2017). Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases. J Neurosurg, 127(5), 1096-1104.
- Jensen RL, Alzhrani G, Kestle JRW, Brockmeyer DL, Lamb SM, Couldwell WT (2017). Neurosurgeon as educator: a review of principles of adult education and assessment applied to neurosurgery. J Neurosurg, 127(4), 949-957.
- Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC (2017). Adjuvant radiotherapy for atypical meningiomas. J Neurosurg, 126(6), 1822-1828.
- Huang LE, Cohen AL, Colman H, Jensen RL, Fults DW, Couldwell WT (2017). IGFBP2 expression predicts IDH-mutant glioma patient survival. Oncotarget, 8(1), 191-202.
- Bagshaw HP, Ly D, Jensen RL, and Shrieve DC (2016). Local control after stereotactic radiosurgery for melanoma brain metastases by metastatic lesion. J Radiosurg SBRT, 4, 181-190.
- Kalinina J, Ahn J, Devi NS, Wang L, Li Y, Olson JJ, Glantz M, Smith T, Kim EL, Giese A, Jensen RL, Chen CC, Carter BS, Mao H, He M, Van Meir EG (2016). Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase. Clin Cancer Res, 22(24), 6256-6265.
- Hu N, Richards R, Jensen RL (2016). Role of chromosone 1p/19q co-deletion on the prognosis of oliogodendromagliomas: A systemic review and meta-analysis. Interdiscip Neurosurg, 5, 58-63.
- Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurg, 86, 210-9.
- de Souza PC, Balasubramanian K, Njoku C, Smith N, Gillespie DL, Schwager A, Abdullah O, Ritchey JW, Fung KM, Saunders D, Jensen RL, Towner RA (2015). OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model. J Magn Reson Imaging, 42(6), 1582-91.
- Jensen RL (2015). Predicting Outcomes After Glioma Surgery: Model Behavior. World Neurosurg, 84(4), 894-6.
- Lloyd IE, Clement PW, Salzman KL, Jensen RL, Salama ME, Palmer CA (2015). An unusual and challenging case of HIV-associated primary CNS Lymphoma with Hodgkin-like morphology and HIV encephalitis. Diagn Pathol, 10(1), 152.
- Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, Shrieve DC (2015). Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. J Neurosurg, 123(2), 395-401.
- Karsy M, Sivakumar W, Neil J, Guan J, Moy F, Jensen RL (2015). Meta-analysis of the effect of isocitrate dehydrogenase 1 and 2 mutation on glioblastoma prognosis. Contemp Neurosurg, 37(5), 1-6.
- Choi H, Gillespie DL, Berg S, Rice C, Couldwell S, Gu J, Colman H, Jensen RL, Huang LE (2015). Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression. PLoS One, 10(4), e0125125.
- Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen RL (2015). A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus, 38(3), E4.
- Chen R, Ravindra VM, Cohen AL, Jensen RL, Salzman KL, Prescot AP, Colman H (2015). Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus, 38(3), E2.
- Gillespie DL, Aguirre MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa JT, Wang L, King R, Wang X, Tan M, Malamas A, Lu ZR, Jensen RL (2014). RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. J Neurosurg, 122(2), 331-41.
- Gillespie DL, Arce-Larreta MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa J, Wang L, Wang X, Lu Z-R, Jensen RL (2015). RNA interference targeting HIF-1a via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. J Neurosurg, 122(2), 331-341.
- Womeldorff M, Gillespie D, Jensen RL (2014). Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus, 37(6), E8.
- Kent T, Jensen RL (2014). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part II -- Brain Shift, Perioperative Complications, and Costs. Contemp Neurosurg, 36(23).
- Kent T, Jensen RL (2014). Intraoperative Magnetic Resonance Imaging in Neurosurgery: Part 1 -- A Review of History, Use, and Outcomes. Contemp Neurosurg, 36(23).
- Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL (2014). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro Oncol, 16(2), 280-91.
- Terakedis BE, Jensen RL, Shrieve DC (2014). Tumor Control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for bran metastases. (3), 21-28.
- Ghia A, Jensen RL, Sherieve A, Hu N, Li X, Shrieve D (2014). Radiosurgery for melanoma brain metastases: the impact of hemorrhage on local control. (3), 43-50.
- Wagner AE, Chen A, Jensen RL, Shrieve DC (2014). Stereotactic radiosurgery for solitary brain metastases: Factors impacting control. J Radiosurg SBRT, 3(2), 111-121.
- Jensen RL (2014). Educating our residents for the alphabet soup of PQRS and HCAHPS. 23(4).
- Schabel MC, DiBella EV, Jensen RL, Salzman KL (2010). A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results. Phys Med Biol, 55(16), 4807-23.
- Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC (2010). Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol, 98(2), 253-63.
- Mumert ML, Walsh MT, Jensen EM, Jensen RL (2009). Pleomorphic liposarcoma originating from intracranial dura mater. J Neurooncol, 97(1), 149-53.
- Ragel BT, Couldwell WT, Gillespie DL, Jensen RL (2007). Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev, 30(3), 181-7; discussion 187.
Review
- Hu N, Cheng H, Zhang K, Jensen R (2017). Evaluating the Prognostic Accuracy of Biomarkers for Glioblastoma Multiforme Using The Cancer Genome Atlas Data. [Review]. Cancer Inform, 16, 1176935117734844.
- Karsy M, Guan J, Cohen AL, Jensen RL, Colman H (2017). New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M. [Review]. Curr Neurol Neurosci Rep, 17(2), 19.
- Karsy M, Guan J, Cohen A, Colman H, Jensen RL (2016). Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons. [Review]. Neurosurg Clin N Am, 27(2), 249-60.
Edited Book
- Zada G, Jensen RL (Eds.) (April 2016). Neurosurgery Clinics of North America.
- G Zada, RL Jensen (Eds.) (2015). Neurosurgery Clinics of North America.
Book Chapter
- Abou Al-Shaar H, Jensen RL, Couldwell WT (2020). Primary central nervous system lymphoma. In R Nader, A Sabbagh, SK Elbabaa, H Al-Jehani, J Gasco, C Gragniello (Eds.), Neurosurgery Case Review: Questions and Answers (2nd edition). New York: Thieme.
- Weaver BD, Jensen RL (2018). Hemangiopericytoma. In Lonser R, Elder B (Eds.), Cases in Surgical Neuro-oncology. New York: Oxford University Press.
- Weaver BD, Jensen RL (2017). Posterior fossa metastases. In Couldwell WT (Ed.), Skull Base Surgery of the Posterior Fossa. New York: Springer.
- Jensen RL (In press). Awake craniotomy for resection of brain tumor using intraoperative cortical mapping and intraoperative magnetic resonance imaging. In Masters of Neurosurgery.
Case Report
- Ravindra VM, Braca JA 3rd, Jensen RL, Duckworth EA (2015). Management of intracranial pathology during pregnancy: Case example and review of management strategies. Surg Neurol Int, 6, 43.
- Mazur MD, Neil JA, Agarwal C, Jensen RL, Couldwell WT (2015). Surgical management of a transosseous meningioma with invasion of torcula, superior sagittal sinus, transverse sinus, calvaria, and scalp. Surg Neurol Int, 6, 40.
Editorial
- Amin-Hanjani S, Bambakidis NC, Barker FG, Carter BS, Cockroft KM, Du R, Fraser JF, Hamilton MG, Huang J, Jane JA, Jensen RL, Kaplitt MG, Kaufmann AM, Pilitsis JG, Riina HA, Schulder M, Vogelbaum MA, Yang LJS, Zada G (2020). Editorial. COVID-19 and neurosurgical practice: an interim report. J Neurosurg, 1-2.
- Zada G, Jensen RL (2016). Meningiomas: An Update on Diagnostic and Therapeutic Approaches. Neurosurg Clin N Am, 27(2), xiii.
- Jensen RL (2014). Navigated transcranial magnetic stimulation: another tool for preoperative planning for patients with motor-eloquent brain tumors. Neuro Oncol, 16(10), 1299-300.
Abstract
- Frandsen J, Orton A, Shrieve DS, Jensen RL, Colman H, Cohen H, Tward J, and Suneja G (2016). U.S. patterns of care and outcomes for gliosarcoma; a National Cancer Database Project [Abstract]. Int J Radiat Oncol Biol Phys, 96(2 suppl), E96.
Global Impact
News Articles
Huntsman Cancer Institute News
The Scope & Other Podcasts
- Department of Neurosurgery Program Overview
- Why Utah for Neurosurgery Residency?
- Residency Welcome From the Program Director
- Why Choose Utah for Neurosurgery Residency?
- Intraoperative MRI for Treatment and Research of Glioma
- A Clinical Approach to Non Spondylotic Myelopathies
- Talks with Docs - Randy Jensen, MD, PhD
- Advances in the Surgical Management of Glioma: Intraoperative MRI, Cortical Mapping and Navigation
- IMRI at HCI
- Brain, Spine, and Skull Base Cancer Program at Huntsman Cancer Institute
- Why Salt Lake City
- Welcome
- Randy Jensen